Chiron Real Estate Inc. (XRN)
| Market Cap | 458.65M -10.9% |
| Revenue (ttm) | 151.53M +9.6% |
| Net Income | -14.97M |
| EPS | -1.12 |
| Shares Out | 13.68M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | $1.92 (5.73%) |
| Ex-Dividend Date | May 20, 2026 |
| Volume | 113,706 |
| Open | 34.40 |
| Previous Close | 34.58 |
| Day's Range | 33.51 - 34.52 |
| 52-Week Range | 29.05 - 39.93 |
| Beta | 1.14 |
| Analysts | Hold |
| Price Target | 38.00 (+13.33%) |
| Earnings Date | May 6, 2026 |
About XRN
Chiron Real Estate Inc. is a net-lease medical REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems. Chiron Real Estate Inc. was established on March 18, 2011 and is based in Bethesda, United States.
Financial Performance
Financial StatementsAnalyst Summary
According to one analyst, the rating for XRN stock is "Hold" and the 12-month stock price target is $38.0.
News
Chiron Real Estate price target lowered to $40 from $42 at Alliance Global
Alliance Global lowered the firm’s price target on Chiron Real Estate (XRN) to $40 from $42 and keeps a Buy rating on the shares. The firm updated the company’s model…
Chiron Real Estate Earnings Call Transcript: Q1 2026
Repositioning toward senior housing, over 25% of assets now in SHOP, with $425M in new investments funded by capital recycling, retained cash flow, and a $100M strategic investment. Dividend reduced to support growth; long-term earnings growth of 6% targeted by 2028.
Chiron Real Estate downgraded to Neutral from Buy at Compass Point
Compass Point analyst Merrill Ross downgraded Chiron Real Estate (XRN) to Neutral from Buy with a price target of $38, down from $50. The company has shifted from investing in…
Chiron Real Estate acquires $425M in SHOP communities
Chiron Real Estate (XRN) announced that it has entered into purchase agreements relating to the acquisition of three seniors housing communities from affiliates of Silverstone Senior Living for an agg...
Chiron Real Estate reports Q1 FFO 97c vs. $1.02 last year
Reports Q1 revenue $38.1M, consensus $38.1M. Mark Decker, Jr., Chief Executive Officer and President stated, “Chiron is repositioning as a growth-oriented investor. Central to this transition is a dis...
Chiron Real Estate Inc. Enters into Agreements to Acquire $425 Million of SHOP Communities
BETHESDA, Md.--(BUSINESS WIRE)--Chiron Real Estate Inc. (NYSE: XRN) (the “Company” or “Chiron”), today announced that it has entered into purchase agreements relating to the acquisition of three senio...
Chiron Real Estate Inc. Announces $100 Million Strategic Convertible Perpetual Preferred Equity Investment Led by Maewyn Capital Partners
BETHESDA, Md.--(BUSINESS WIRE)--Chiron Real Estate Inc. (NYSE: XRN) (the “Company” or “Chiron”), today announced the entry into an agreement providing for up to a $100 million delayed-draw convertible...
Chiron Real Estate Inc. Announces First Quarter 2026 Financial Results
BETHESDA, Md.--(BUSINESS WIRE)--Chiron Real Estate Inc. (NYSE: XRN) (the “Company” or “Chiron”), today announced financial results for the three months ended March 31, 2026 and other data. Mark Decker...
Chiron Real Estate Inc. Announces Dates for 2026 First Quarter Earnings Release and Webcast
BETHESDA, Md.--(BUSINESS WIRE)--Chiron Real Estate Inc. (NYSE: XRN) (the “Company”), announced today that it intends to release its first quarter 2026 financial results after the market closes on Wedn...
Chiron Real Estate management to meet with Citizens
Meeting to be held on April 8 in Chicago hosted by Citizens.
Chiron Real Estate price target raised to $42 from $40 at Alliance Global
Alliance Global analyst Gaurav Mehta raised the firm’s price target on Chiron Real Estate (XRN) to $42 from $40 and keeps a Buy rating on the shares. The firm cites…
Chiron Real Estate Earnings Call Transcript: Q4 2025
Expanded into senior housing and active adult segments to capture demographic-driven growth, while maintaining stable medical office performance. Improved leverage, initiated asset recycling, and set 2026 Core FFO guidance at $4.30–$4.45 per share.
Chiron Real Estate reports Q4 core FFO $1.16 vs. $1.09 last year
Fourth quarter same-property cash net operating income growth was 5.4% on a year-over-year basis.
Chiron Real Estate sees FY26 core FFO $4.30-$4.45
16:13 EST Chiron Real Estate (XRN) sees FY26 core FFO $4.30-$4.45
Chiron Real Estate Inc. Announces Fourth Quarter and Full Year 2025 Financial Results
BETHESDA, Md.--(BUSINESS WIRE)--Chiron Real Estate Inc. (NYSE: XRN) (the “Company” or “Chiron”), today announced financial results for the three and twelve months ended December 31, 2025 and other dat...
Global Medical REIT Inc. Announces Dates for 2025 Fourth Quarter and Year-End Earnings Release and Webcast
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), announced today that it intends to release its fourth quarter and year-end 2025 financial results after...
Global Medical REIT Inc. Announces Strategic Rebrand to Chiron Real Estate Inc.
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) today announced that the Company will change its name, effective as of 12:01 a.m., Eastern Time, on Febr...
Global Medical REIT Reports Tax Treatment of 2025 Dividends
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), announced today that information regarding the federal income tax treatment of the dividends paid in 20...
Global Medical REIT Inc. Announces Henry Cole Stepping Down from its Board of Directors
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) today announced that Henry Cole has notified the Board of Directors (the “Board”) that he plans to step ...
Global Medical REIT Inc. Announces Retirement of Ronald Marston from its Board of Directors and Declares 2025 Fourth Quarter Common and Preferred Dividends
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) today announced that Ronald Marston has notified the Board of Directors (the “Board”) that he plans to r...
Global Medical REIT Inc. Announces Pricing of Public Offering of 8.00% Series B Preferred Stock
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE:GMRE) (the “Company”) today announced the pricing of the underwritten public offering of 2,000,000 shares of its 8.00% Series B Cumulativ...
Global Medical REIT Inc. Announces Proposed Public Offering of Series B Preferred Stock
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE:GMRE) (the “Company”) today announced the commencement of an underwritten public offering of shares of its Series B Cumulative Redeemable...
Chiron Real Estate Earnings Call Transcript: Q3 2025
Third-quarter results showed 2.7% same-store NOI growth, 95% occupancy, and 4% year-over-year AFFO per share growth. The company extended debt maturities, maintained disciplined capital allocation, and expects occupancy to reach 96% by year-end.
Global Medical REIT Announces Third Quarter 2025 Financial Results
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), today announced financial results for the three and nine months ended September 30, 2025 and other data...
Global Medical REIT Inc. Announces Dates for 2025 Third Quarter Earnings Release and Webcast
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), announced today that it intends to release its third quarter 2025 financial results after the market cl...